General form of registration statement for all companies including face-amount certificate companies

STATEMENTS OF STOCKHOLDERS' EQUITY

v2.3.0.15
STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
Total
USD ($)
Pre Acquisition
USD ($)
Cash
USD ($)
Professional Services
USD ($)
licensed technology
USD ($)
Convertible Debt
USD ($)
Series C Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
USD ($)
Series E Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
USD ($)
Private Placement
Pre Acquisition
USD ($)
Public Offering
Pre Acquisition
USD ($)
Preferred Stock and Dividend
Pre Acquisition
USD ($)
Common Stock
USD ($)
Common Stock
Pre Acquisition
USD ($)
Common Stock
Cash
USD ($)
Common Stock
Professional Services
USD ($)
Common Stock
licensed technology
USD ($)
Common Stock
Convertible Debt
USD ($)
Common Stock
Series C Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
Common Stock
Series E Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
USD ($)
Common Stock
Private Placement
Pre Acquisition
USD ($)
Common Stock
Public Offering
Pre Acquisition
USD ($)
Common Stock
Preferred Stock and Dividend
Pre Acquisition
USD ($)
Additional Paid-in Capital
USD ($)
Additional Paid-in Capital
Pre Acquisition
USD ($)
Additional Paid-in Capital
Cash
USD ($)
Additional Paid-in Capital
Professional Services
USD ($)
Additional Paid-in Capital
licensed technology
USD ($)
Additional Paid-in Capital
Convertible Debt
USD ($)
Additional Paid-in Capital
Series C Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
USD ($)
Additional Paid-in Capital
Series E Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
USD ($)
Additional Paid-in Capital
Private Placement
Pre Acquisition
USD ($)
Additional Paid-in Capital
Public Offering
Pre Acquisition
USD ($)
Additional Paid-in Capital
Preferred Stock and Dividend
Pre Acquisition
USD ($)
Deficit Accumulated During the Development Stage
USD ($)
Redeemable Preferred Stock Series D and E Convertible Preferred Stock
Pre Acquisition
USD ($)
Redeemable Preferred Stock Series D and E Convertible Preferred Stock
Series E Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
USD ($)
Redeemable Preferred Stock Series D and E Convertible Preferred Stock
Preferred Stock and Dividend
Pre Acquisition
USD ($)
Series C Cumulative Convertible Preferred Stock
Pre Acquisition
Series C Cumulative Convertible Preferred Stock
Series C Convertible Preferred Stock and Accumulated Dividends
Pre Acquisition
Series C Cumulative Convertible Preferred Stock
Preferred Stock and Dividend
Pre Acquisition
Accumulated Deficit
Pre Acquisition
USD ($)
Beginning Balance at Nov. 06, 2002                                                                                  
Issuance of common stock (in shares)                           6,440,123 101,220                                                    
Issuance of common stock     $ 590,269 $ 9,108                   $ 64 $ 1                   $ 590,205 $ 9,107                              
Ending Balance at Dec. 31, 2002 599,377                     65                     599,312                                    
Ending Balance (in shares) at Dec. 31, 2002                       6,541,343                                                          
Net income (loss) (295,790)                                                                 (295,790)              
Issuance of common stock (in shares)                           37,958   203,483                                                  
Issuance of common stock     4,937   80,412                     2                 4,937   80,410                            
Ending Balance at Dec. 31, 2003 388,936                     67                     684,659                     (295,790)              
Ending Balance (in shares) at Dec. 31, 2003                       6,782,784                                                          
Net income (loss) (342,761)                                                                 (342,761)              
Ending Balance at Dec. 31, 2004 46,175                     67                     684,659                     (638,551)              
Ending Balance (in shares) at Dec. 31, 2004                       6,782,784                                                          
Net income (loss) (481,837)                                                                 (481,837)              
Issuance of common stock (in shares)                           610,664                                                      
Issuance of common stock     835,868                     6                     835,862                                
Ending Balance at Dec. 31, 2005 400,206                     73                     1,520,521                     (1,120,388)              
Beginning Balance (in shares) at Dec. 31, 2005                       7,393,448                                                          
Common stock repurchased (in shares)                       (43,819)                                                          
Common stock repurchased (31,667)                                           (31,667)                                    
Stock-based compensation 43,994                                           43,994                                    
Net income (loss) (963,440)                                                                 (963,440)              
Issuance of common stock (in shares)                           2,202,179                                                      
Issuance of common stock     7,097,072                     22                     7,097,050                                
Ending Balance at Dec. 31, 2006 6,546,165                     95                     8,629,898                     (2,083,828)              
Ending Balance (in shares) at Dec. 31, 2006                       9,551,808                                                          
Exercise of warrant to purchase common stock (in shares)                       75,045                                                          
Exercise of warrant to purchase common stock 250,000                     1                     249,999                                    
Stock-based compensation 570,392                                           570,392                                    
Net income (loss) (5,090,325)                                                                 (5,090,325)              
Issuance of common stock (in shares)                           60,250                                                      
Issuance of common stock     250,000                     1                     249,999                                
Ending Balance at Dec. 31, 2007 2,526,232                     97                     9,700,288                     (7,174,153)              
Ending Balance (in shares) at Dec. 31, 2007                       9,687,103                                                          
Stock-based compensation 477,488                                           477,488                                    
Net income (loss) (6,090,715)                                                                 (6,090,715)              
Issuance of common stock (in shares)                           3,132,999                                                      
Issuance of common stock     12,931,562                     31                     12,931,531                                
Ending Balance at Dec. 31, 2008 9,844,567 (19,488,601)                   128 3.0                   23,109,307 40,204,549                   (13,264,868) 13,904,100           (59,693,153)
Ending Balance (in shares) at Dec. 31, 2008                       12,820,102 287,423                                           413.5     272      
Reclassification of warrants to derivative liability (see Note 2)   (998,945)                                           (6,893,316)                                 5,894,371
Issuance of common stock and warrants (in shares)                                       89,126                                          
Issuance of common stock and warrants                 8,938,884                     1                     8,938,883                    
Exercise of warrant to purchase common stock (in shares)                         3,162                                                        
Exercise of warrant to purchase common stock   1,000,962                                           1,000,962                                  
Issuance of common stock in exchange for warrants (in shares)                         13,623                                                        
Issuance of common stock in exchange for warrants   1,625,760                                           1,625,760                                  
Compensation expense associated with options issued to employees   437,066                                           437,066                                  
Stock-based compensation 502,199                                           502,199                                    
Compensation expense (benefit) associated with options issued to non-employees   427,271                                           427,271                                  
Issuance of Series E redeemable convertible preferred stock and warrants, net of issuance costs of $795,469 (in shares)                                                                     200            
Issuance of Series E redeemable convertible preferred stock and warrants, net of issuance costs of $795,469   2,907,208                                           2,907,208                     6,297,323            
Issuance of Series E redeemable convertible preferred stock in payment of accumulated dividends(in shares)                                                                     31.942875            
Issuance of Series E redeemable convertible preferred stock in payment of accumulated dividends                                                                     1,597,144            
Adjustment to record the carrying value of Series E redeemable convertible preferred stock at fair value on the date of sale   125,892                                           125,892                     (125,892)            
Fair value of the extension of expiration date of warrants   839,923                                           839,923                                  
Accretion of deemed dividend associated with the extension of expiration date of warrants   (839,923)                                           (839,923)                                  
Dividends accrued on preferred stock   (3,296,289)                                           (3,296,289)                                  
Net income (loss) (6,219,873) (22,273,306)                                                               (6,219,873)             (22,273,306)
Conversion of Convertible Securities (in shares)                                   10,058 51,889                                 (97.18209375)     (68)    
Conversion of Convertible Securities             184,246 3,514,314                     1                   184,246 3,514,313           (32,130,560)          
Ending Balance at Dec. 31, 2009 4,126,893 (26,895,538)                   128 5                   23,611,506 49,176,545.00000000                   (19,484,741) 18,459,619.00000000           (76,072,088.00000000)
Ending Balance (in shares) at Dec. 31, 2009                       12,820,102 455,281                                           548.26078125     204      
Net income (loss)   5,350,122                                                                              
Ending Balance at Mar. 31, 2010                                                                                  
Beginning Balance at Dec. 31, 2009 4,126,893 (26,895,538)                   128 5                   23,611,506 49,176,545.00000000                   (19,484,741)             (76,072,088.00000000)
Beginning Balance (in shares) at Dec. 31, 2009                       12,820,102 455,281                                                 204      
Exercise of stock options   158,567                                           158,567                                  
Exercise of stock options (in shares)                         5,991                                                        
Issuance of common stock and warrants (in shares)                                         140,056                                        
Issuance of common stock and warrants                   744,911                     1                     744,910                  
Intrinsic value of beneficial conversion feature associated with the conversion of convertible debt 213,792                                           213,792                                    
Exercise of warrant to purchase common stock (in shares)                         53,478                                                        
Exercise of warrant to purchase common stock   2,584,397                     1                     2,584,396                                  
Compensation expense associated with options issued to employees   586,321                                           586,321                                  
Stock-based compensation 353,340                                           353,340                                    
Compensation expense (benefit) associated with options issued to non-employees   (249,023)                                           (249,023)                                  
Fair value of incremental shares issued to preferred stockholders in connection with exchange of preferred stock for common stock   11,955,151                                           11,955,151                                  
Fair value of warrants issued to preferred shareholders   586,050                                           586,050                                  
Accretion of deemed dividend associated with the issuance of warrants to preferred stockholders   (586,050)                                           (586,050)                                  
Accretion of deemed dividend associated with the incremental shares of common stock issued in connection with the exchange of preferred stock   (11,955,151)                                           (11,955,151)                                  
Dividends accrued on preferred stock   (2,207,827)                                           (2,207,827)                                  
Net income (loss) (4,560,263) 2,095,392                                                               (4,560,263)             2,095,392
Conversion of Convertible Securities (in shares)                                     76,770     2,228,338                           (139.99673625) (408.264045)     (204)  
Conversion of Convertible Securities               5,324,518     19,064,891.000000               1     22               5,324,517     19,064,869.000000     (4,689,593) (13,770,026.000000)        
Ending Balance at Dec. 31, 2010 133,762 1,206,609                     30                   24,178,638 75,183,275                   (24,045,004)             (73,976,696)
Ending Balance (in shares) at Dec. 31, 2010                         2,959,914                                                        
Net income (loss)   (1,010,072)                                                                              
Ending Balance at Mar. 31, 2011   304,915                                                                              
Beginning Balance at Dec. 31, 2010 133,762                     128                     24,178,638                     (24,045,004)              
Beginning Balance (in shares) at Dec. 31, 2010                       12,820,102                                                          
Issuance of common stock in a business combination (in shares)                       2,959,871                                                          
Issuance of common stock in a business combination 2,219,903                     30                     2,219,873                                    
Cash paid in lieu of fractional shares in a business combination, (in shares)                       (41)                                                          
Cash paid in lieu of fractional shares in a business combination (145)                                           (145)                                    
Issuance of common stock and warrants (in shares)                       6,846,537                                                          
Issuance of common stock and warrants 4,866,406                     68                     4,866,338                                    
Intrinsic value of beneficial conversion feature associated with the conversion of convertible debt 257,973                                           257,973                                    
Exercise of warrant to purchase common stock (in shares)                       18,153                                                          
Exercise of warrant to purchase common stock 48,339                                           48,339                                    
Stock-based compensation 655,656                                           655,656                                    
Net income (loss) (5,469,502)                                                                 (5,469,502)              
Conversion of Convertible Securities (in shares)                                 4,181,535                                                
Conversion of Convertible Securities           3,184,707                     42                     3,184,665                          
Ending Balance at Sep. 30, 2011 $ 5,897,099                     $ 268                     $ 35,411,337                     $ (29,514,506)              
Ending Balance (in shares) at Sep. 30, 2011                       26,826,157